NCT03787719

Brief Summary

Thrice-weekly dialysis is the accepted standard of care for hemodialysis (HD) patients. Observational studies suggest that elderly HD patients do as well and have better quality of life with less dialysis (ie twice-weekly). We propose a single-center pilot study of 40 patients to determine the feasibility of a large randomized controlled trial (RCT) designed to determine the impact of HD frequency on well-being in new HD patients above the age of 70. The primary outcomes will be metrics of feasibility and safety. We hypothesize that an adequately powered RCT that will determine whether elderly patients who dialyze twice weekly have improved well-being compared to thrice-weekly is feasible

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
49

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 27, 2018

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

December 11, 2018

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 26, 2018

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 11, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 9, 2023

Completed
Last Updated

May 1, 2024

Status Verified

April 1, 2024

Enrollment Period

5.2 years

First QC Date

December 11, 2018

Last Update Submit

April 30, 2024

Conditions

Keywords

Twice weekly dialysisThrice weekly dialysisEnd Stage Renal Disease

Outcome Measures

Primary Outcomes (5)

  • Recruitment

    Successful recruitment will be defined as \>3-4 patients/month over 12 months providing informed consent and meeting criteria for randomization.

    1 year

  • percent of prescribed treatments completed by patient

    Successful adherence will be defined as =\> 90% of intervention being adhered to.

    1 year

  • Loss to trial completion

    Successful loss to trial completion will be defined as = \>50% of randomized patients completing the 12 month trial. Based on our data, the anticipated reasons for loss to trial completion will be death and moving away from the study center.

    1 year

  • Percent of weekly potassium values falling within normal range.

    Potassium will be measured every week for the duration of the study.

    1 year

  • Percent of weekly post hemodialysis weights that are within 1 kg of prescribed dry weight

    Prescribed and acheived post HD weight will be recorded weekly.

    1 year

Secondary Outcomes (1)

  • Change in Patient's Quality of Life - Using Edmonton Symptom Assessment System (ESAS-R)

    1 year

Study Arms (2)

Twice per week dialysis

EXPERIMENTAL

Twice-weekly 4 hour dialysis treatment (Monday and Friday or Tuesday and Saturday).

Other: Twice per week dialysis

Thrice per week dialysis

NO INTERVENTION

Standard thrice-weekly 4 hour dialysis treatment (Monday, Wednesday and Friday or Tuesday, Thursday and Staurday)

Interventions

Twice-weekly 4 hour dialysis treatment

Twice per week dialysis

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • Greater than equal 70 years old, planned ongoing in-center HD treatment
  • Incident HD patient and still alive 7 weeks post HD initiation
  • Patient or substitute decision maker provide informed consent

You may not qualify if:

  • Significant barriers to ascertainment of the patient-reported experience measures
  • Patient currently admitted to hospital without Alternate Level of Care designation
  • Patient non-adherent to dialysis prescription

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kingston Health Sciences Centre (KHSC)

Kingston, Ontario, K7L 2V7, Canada

Location

MeSH Terms

Conditions

Kidney Failure, Chronic

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Single center pilot study
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 11, 2018

First Posted

December 26, 2018

Study Start

June 27, 2018

Primary Completion

September 11, 2023

Study Completion

November 9, 2023

Last Updated

May 1, 2024

Record last verified: 2024-04

Locations